Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether transarterial chemoembolization containing
arsenic trioxide is safe and effective in the treatment of intermediate-stage hepatocellular
carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
First Hospital of China Medical University
Collaborators:
Fudan University Sun Yat-sen University Xijing Hospital Zhongda Hospital